ANDREAS S

Chief Financial Officer Board Member
Cardiology
AOP Orphan
Albania

Business Expert Cardiology
Biography

Andreas Steiner is an economist but has in-depth knowledge of the industry thanks to his long career in the healthcare sector, enabling him to bring both specific expertise and strategic vision. He was in charge of the Finance and Administration division at Wellcome Austria Pharma from 1989 to 1995, and was ultimately responsible for the set up and expansion of Wyeth Pharmaceuticals in Austria and Eastern Europe as Director of Finance & Administration (Chief Financial Officer) from 1995 to 2006.  The key focus of his activities was on setting up and organizing subsidiaries and representative offices, together with the associated challenges regarding financial management, supply chain and IT. In 2007, he moved from the pharmaceutical industry to Tiroler Landeskrankenanstalten (Hospital Association of Tyrol, TILAK), where, as an Executive Board member, he learned about the Austrian healthcare system from another perspective, acquiring in-depth knowledge about managing a public organization and through the cooperation with the Medical University. At AOP Orphan, he is the Executive Board member responsible for strategic financial management and the optimization of organizational workflows. Andreas Steiner is an economist but has in-depth knowledge of the industry thanks to his long career in the healthcare sector, enabling him to bring both specific expertise and strategic vision. He was in charge of the Finance and Administration division at Wellcome Austria Pharma from 1989 to 1995, and was ultimately responsible for the set up and expansion of Wyeth Pharmaceuticals in Austria and Eastern Europe as Director of Finance & Administration (Chief Financial Officer) from 1995 to 2006.  The key focus of his activities was on setting up and organizing subsidiaries and representative offices, together with the associated challenges regarding financial management, supply chain and IT. In 2007, he moved from the pharmaceutical industry to Tiroler Landeskrankenanstalten (Hospital Association of Tyrol, TILAK), where, as an Executive Board member, he learned about the Austrian healthcare system from another perspective, acquiring in-depth knowledge about managing a public organization and through the cooperation with the Medical University. At AOP Orphan, he is the Executive Board member responsible for strategic financial management and the optimization of organizational workflows.

Research Intrest

Cardiology